- Home
- CNFR vs MIRA Comparison
CNFR vs MIRA Comparison
Compare CNFR & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNFR
- MIRA
- Stock Information
- Founded
- CNFR 2009
- MIRA 2020
- Country
- CNFR United States
- MIRA United States
- Employees
- CNFR N/A
- MIRA N/A
- Industry
- CNFR Property-Casualty Insurers
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- CNFR Finance
- MIRA Health Care
- Exchange
- CNFR Nasdaq
- MIRA Nasdaq
- Market Cap
- CNFR 14.9M
- MIRA 17.1M
- IPO Year
- CNFR 2015
- MIRA 2023
- Fundamental
- Price
- CNFR $1.19
- MIRA $1.47
- Analyst Decision
- CNFR
- MIRA Strong Buy
- Analyst Count
- CNFR 0
- MIRA 2
- Target Price
- CNFR N/A
- MIRA $14.00
- AVG Volume (30 Days)
- CNFR 23.2K
- MIRA 3.6M
- Earning Date
- CNFR 11-13-2024
- MIRA 11-12-2024
- Dividend Yield
- CNFR N/A
- MIRA N/A
- EPS Growth
- CNFR N/A
- MIRA N/A
- EPS
- CNFR N/A
- MIRA N/A
- Revenue
- CNFR $96,847,000.00
- MIRA N/A
- Revenue This Year
- CNFR N/A
- MIRA N/A
- Revenue Next Year
- CNFR $7.00
- MIRA N/A
- P/E Ratio
- CNFR N/A
- MIRA N/A
- Revenue Growth
- CNFR N/A
- MIRA N/A
- 52 Week Low
- CNFR $0.65
- MIRA $0.51
- 52 Week High
- CNFR $1.91
- MIRA $6.40
- Technical
- Relative Strength Index (RSI)
- CNFR 52.76
- MIRA 48.43
- Support Level
- CNFR $1.10
- MIRA $1.65
- Resistance Level
- CNFR $1.26
- MIRA $1.75
- Average True Range (ATR)
- CNFR 0.09
- MIRA 0.33
- MACD
- CNFR -0.00
- MIRA -0.03
- Stochastic Oscillator
- CNFR 39.13
- MIRA 13.01
About CNFR Conifer Holdings Inc.
Conifer Holdings Inc is an insurance company engaged in the sale of property and casualty insurance products. It is engaged in three classes of insurance businesses namely commercial lines, personal lines, and wholesale agency business. Within these three businesses, the company offers various insurance products and insurance agency services. The company views the commercial and personal lines segments as underwriting business. The wholesale agency business provides non-risk bearing revenue through commissions and policy fees. Its revenues are derived from premiums earned from insurance operations.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.